Status:
COMPLETED
A Study To Estimate The Effect Of Omeprazole On The Pharmacokinetics Of Nelfinavir In Healthy Subjects
Lead Sponsor:
Pfizer
Collaborating Sponsors:
Jasper Clinic, Michigan
Conditions:
Healthy Volunteers
Eligibility:
All Genders
18-55 years
Phase:
PHASE4
Brief Summary
To estimate the effects of omeprazole on the pharmacokinetics of nelfinavir in healthy subjects
Eligibility Criteria
Inclusion
- Healthy male or female subjects between the ages of 18 and 55 years.
Exclusion
- Subjects with hematological, renal, endocrine, pulmonary, gastrointestinal, cardiovascular, hepatic, psychiatric, neurologic, or allergic disease.
Key Trial Info
Start Date :
November 1 2005
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2006
Estimated Enrollment :
20 Patients enrolled
Trial Details
Trial ID
NCT00251030
Start Date
November 1 2005
End Date
January 1 2006
Last Update
February 16 2009
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Pfizer Investigational Site
Kalamazoo, Michigan, United States, 49007